Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
2012 ◽
Vol 96
(1)
◽
pp. 94-100
◽
2008 ◽
Vol 41
(10)
◽
pp. 873-879
◽
2009 ◽
Vol 89
(2)
◽
pp. 231-237
◽
2008 ◽
Vol 46
(10)
◽
pp. 3311-3318
◽
2018 ◽
Vol 11
(10)
◽
pp. 931-941
◽
2019 ◽
Vol 25
(9)
◽
pp. e298-e299
2016 ◽
Vol 31
(5)
◽
pp. 961-970
◽